Table 1.

Magnitude of NAFLD—Summary of Western Perspective.

Magnitude of NAFLD	Frequenciesa	Reference
Prevalence of NAFLD in the USA	24%	2, 6
Prevalence of NAFLD in South America	31%	2, 6
Prevalence of NAFLD in Europe	23.71%	2, 6
NAFLD prevalence in Hispanic-Americans	24.1%	2, 6
NALFD prevalence in African Americans	13.5%	2, 6
Lifetime cost of patients with NASH (in 2017 US$)	222.6	3
Prevalence of NAFLD risk factors
Obesity	39.8%	21
Diabetes	9.8%	23
Chronic kidney disease	6.9%	70
Obstructive sleep apnea	6.5%	41, 42
Leading indication for liver transplantation in women in the USA	NAFLD	112
Second leading cause of liver transplantation in the USA	NAFLD	111
Post-LT survival for NASH at 1 year	88%	114
Post-LT survival for NASH at 3 years	82%	114
Post-LT survival for NASH at 5 years	77%	114
NAFLD recurrence after LT	15–100%	119

NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis.

^aFrequencies reported unless stated otherwise.